Project Grant R21AI180914

Award Date 5/22/24
Completion Date 3/31/26
Dollars Obligated $911K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21205, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to develop a new strategy for linking quantitative bacterial traits to host cell mutations. The $256,995 award to Tufts University School of Medicine will fund research to measure two key intracellular traits of the pathogen Legionella pneumophila - iron starvation and fitness - and use optical sequencing techniques to...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $143,784 to The Johns Hopkins University to conduct research characterizing how the bacterium Legionella pneumophila, the causative agent of Legionnaires' disease, inhibits host cell translation. The research seeks to: 1) determine the mechanism of the Legionella effector protein SidL in disrupting host cell...
This $2,308,174 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) is funding research to develop new antimicrobial combinations and strategies to combat the threat of drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae. The key products and services being delivered include: Generating novel mechanistic insights into antibiotic resistance mechanisms and bacterial...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $204,347 to the University of Vermont & State Agricultural College to study the intracellular colonization strategies of Salmonella enterica serovar Typhimurium within human intestinal epithelial cells and macrophages. The project aims to characterize the bacterial and host transcripts from subpopulations of...
This $728,497 project grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases will fund research at Idaho State University from August 2022 through July 2025 on the role of metal ion homeostasis in regulating bacterial capsule production. The goal is to identify the molecular mechanisms by which cellular ratios of manganese, zinc, and calcium influence capsule polysaccharide production in Streptococcus pneumoniae, a gram-positive pathogen. Researchers...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $436,144 to Virginia Commonwealth University (VCU) to investigate how the intracellular bacterial pathogen Anaplasma phagocytophilum exploits the host cell's regulated exocytosis process for its own dissemination and transmission. The research aims to 1) interrogate the role of intracellular calcium concentration and...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $1,148,000.00 to The Trustees of Princeton University to develop novel approaches for combating bacterial infections. The key innovations include: Employing a breakthrough single-cell RNA-sequencing method called M3-SEQ to monitor bacterial and host gene expression during infections at a single-cell level, overcoming limitations of...
This $456,977 project grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) aims to elucidate the membrane properties regulating antimicrobial peptide binding to bacterial outer membrane vesicles (OMVs). The research will leverage innovative approaches to study protein-lipid interactions at the single-vesicle and subpopulation levels, in order to uncover the specific OMV characteristics that influence...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $177,467 to Western Kentucky University to study the role of epigenetic changes in the survival and replication of the Legionella pneumophila bacteria. The key objectives are to: 1) examine DNA methylation patterns in macrophages infected with L. pneumophila, and 2) investigate how Legionella nucleomodulins...
This $462,500 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to decipher the genetic regulation of bacterial heterogeneity in response to antibiotic stress using single-cell transcriptomics. The 5-year award period runs from January 1, 2025 through November 30, 2029. The primary research objective is to comprehensively characterize bacterial heterogeneity during...

DISSECTING A SENSORY SYSTEM FOR LEGIONELLA REPLICATION VACUOLE INTEGRITY - PROJECT SUMMARY INFECTIOUS DISEASE IS A MAJOR THREAT TO HUMAN HEALTH WORLDWIDE. THE EMERGENCE OF ANTIBIOTIC RESISTANCE PATHOGENS NECESSITATES THE DEVELOPMENT OF NEW DRUGS TO TREAT INFECTIONS. A FUNDAMENTAL CHALLENGE IN DEVELOPING ANTIBIOTICS IS THAT MANY PATHOGENS REPLICATE INSIDE HOST CELLS RENDERING THEM INACCESSIBLE TO ANTIMICROBIAL AGENTS. THE CRITICAL PROCESSES THAT GOVERN PATHOGEN GROWTH WITHIN HOST CELLS REPRESENT PROMISING NEW TARGETS FOR THERAPEUTIC INTERVENTION. PATHOGENS ENCOUNTER A BROAD ASSORTMENT OF CHALLENGES WITHIN THE HOST. THE ABILITY TO PERCEIVE AND ADAPT TO THESE CHALLENGES IS A CRITICAL DETERMINANT OF VIRULENCE. THESE ADAPTATIONS ARE MEDIATED BY SENSORY SYSTEMS THAT DETECT HOST-IMPOSED INSULT OR ALTERATIONS IN THEIR LOCAL ENVIRONMENT AND DRIVE AN APPROPRIATE RESPONSE. MANY BACTERIAL PATHOGENS THAT GROW INSIDE HOST CELLS DO SO IN SPECIALIZED COMPARTMENTS CALLED REPLICATION VACUOLES. MAINTAINING THE INTEGRITY OF THE REPLICATION VACUOLE IS PARAMOUNT TO BACTERIAL SURVIVAL AND GROWTH AS IT PROVIDES PROTECTION AGAINST HOST SURVEILLANCE SYSTEMS THAT DETECT AND ELIMINATE PATHOGENS. DISRUPTING THIS PROCESS WOULD THUS LIMIT BACTERIAL BURDEN AND ENABLE PATHOGEN KILLING BY THE HOST. DESPITE VACUOLE INTEGRITY BEING PARAMOUNT FOR PATHOGENESIS, THE MECHANISMS RESPONSIBLE AND HOW BACTERIA SENSE AND RESPOND TO DEFECTS IN THIS PROCESS ARE POORLY UNDERSTOOD. WE HAVE IDENTIFIED A CELL-SURFACE SIGNALING SYSTEM EMPLOYED BY THE BACTERIAL PATHOGEN LEGIONELLA THAT PLAYS A CENTRAL ROLE IN PROMOTING VACUOLE INTEGRITY. LEGIONELLA IS THE CAUSATIVE AGENT OF A LIFE-THREATENING PNEUMONIA CALLED LEGIONNAIRE'S DISEASE AND A WORLD-WIDE HEALTH PROBLEM. THE GOAL OF THIS RESEARCH IS TO CHARACTERIZE HOW SIGNALS ARE PROPAGATED AND THE RESPONSE PATHWAY THAT COMPENSATES ENSURES VACUOLE STABILITY. THIS WORK WILL DEFINE AN UNPRECEDENTED MOLECULAR SURVEILLANCE SYSTEM EMPLOYED BY A VACUOLAR PATHOGEN TO SUSTAIN ITS REPLICATION COMPARTMENT AND THUS, A NEW PARADIGM IN MICROBIAL PATHOGENESIS. AS VACUOLE INTEGRITY PLAYS IS A CENTRAL ROLE IN DEFINING THE VIRULENCE OF NUMEROUS INTRACELLULAR PATHOGENS, THIS WORK WILL HAVE BROAD IMPLICATIONS ACROSS THE FIELD OF MICROBIAL PATHOGENESIS. THIS WORK WILL PROVIDE UNPRECEDENTED INSIGHT INTO A CRITICAL EVENT THAT DETERMINES THE OUTCOME OF AN INFECTION AND A MEANS TO DEVELOP NEW STRATEGIES TO TREAT DISEASE.

Posted 5/22/24, 12:00 AM